Migraine headache. Migraine
Conditions
Interventions
Intervention 1: Intervention1: The patients treat with Propranolol (tablet 20 mg, manufactured by Rooz Daru Company) and Magnesium oxide (tablet 250 mg, manufactured by Abidi Company). Intervention 2:
Treatment - Drugs
Placebo
Intervention1: The patients treat with Propranolol (tablet 20 mg, manufactured by Rooz Daru Company) and Magnesium oxide (tablet 250 mg, manufactured by Abidi Company).
Intervention 2: The patients treat with Propranolol (tablet 20 mg, manufactured by Rooz Daru company) and placebo (same Magnesium tablet, contain lactose, manufactured by Ahvaz College of pharmacy).
Sponsors
Vice chancellor for research Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients with history of moderate or severe migraine headache with or without aura. Exclusion criteria: Patient lesser than 15 and more than 50 years old. Women with menstrual migraine; history of active peptic ulcer and severe abdominal discomfort; history of diabetes mellitus; asthma; severe depression; heart failure; Pregnancy; Lactation and patients who suffered from other headaches except migraine.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of headache in month. Timepoint: At admission time,after one month and after 3 month. Method of measurement: Questionnaire form. | — |
Secondary
| Measure | Time frame |
|---|---|
| MIDAS score. Timepoint: At the admission, and after 3 month. Method of measurement: Questionnaire form. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSharareh Ghobadi, MD
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed